Home
VRDN
VRDN News

Latest Viridian Therapeutics Inc. (VRDN) News on November 17, 2024

Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

3 days ago

Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

Business Wire

5 days ago

Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

12 days ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings

Simply Wall St.

17 days ago

Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 10/01/2024

Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock

Business Wire

2 months ago

Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Business Wire

2 months ago

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease

Business Wire

2 months ago

Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease

Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Business Wire

2 months ago

Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results

Business Wire

3 months ago

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Goldman Sachs Predicts up to 165% Surge for These 2 ‘Strong Buy’ Stocks

TipRanks

4 months ago

Goldman Sachs Predicts up to 165% Surge for These 2 ‘Strong Buy’ Stocks

Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

Business Wire

4 months ago

Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease

Business Wire

5 months ago

Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences

Business Wire

6 months ago

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences

Viridian Therapeutics to Participate in Upcoming May Investor Conferences

Business Wire

6 months ago

Viridian Therapeutics to Participate in Upcoming May Investor Conferences

Viridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Viridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GuruFocus.com

6 months ago

Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements

GuruFocus.com

6 months ago

Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results

Business Wire

6 months ago

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024

Business Wire

7 months ago

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

Business Wire

8 months ago

Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

Viridian Therapeutics Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

9 months ago

Viridian Therapeutics Full Year 2023 Earnings: Misses Expectations

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

9 months ago

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer

Business Wire

9 months ago

Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer

Investing.com

10 months ago

Dow futures rebound after Fed-inspired losses; tech earnings in spotlight

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Barrons.com

10 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Analysts Have Made A Financial Statement On First Busey Corporation's (NASDAQ:BUSE) Annual Report

Simply Wall St.

10 months ago

Analysts Have Made A Financial Statement On First Busey Corporation's (NASDAQ:BUSE) Annual Report

Virtu Financial (VIRT) Q4 Earnings Miss on Higher Expenses

Zacks

10 months ago

Virtu Financial (VIRT) Q4 Earnings Miss on Higher Expenses

Business Wire

10 months ago

Hamilton Insurance Group, Ltd. to Report Fourth Quarter 2023 Financial Results on March 6, 2024

GuruFocus.com

10 months ago

First Busey Corp (BUSE) Reports Mixed Q4 Earnings Amid Strategic Acquisitions and Balance Sheet ...

DuPont Stock Plunges on Lousy Guidance. Blame China and ‘Destocking.’

Barrons.com

10 months ago

DuPont Stock Plunges on Lousy Guidance. Blame China and ‘Destocking.’

Compared to Estimates, First Busey (BUSE) Q4 Earnings: A Look at Key Metrics

Zacks

10 months ago

Compared to Estimates, First Busey (BUSE) Q4 Earnings: A Look at Key Metrics

Grow Financial Federal Credit Union Streamlines, Enhances Self-Service Banking Through NCR Atleos Partnership

Business Wire

10 months ago

Grow Financial Federal Credit Union Streamlines, Enhances Self-Service Banking Through NCR Atleos Partnership

Investing.com

10 months ago

Coinbase Global cut at JPMorgan amid Bitcoin ETF skepticism: 4 big analyst cuts

Hamilton Appoints Jamie Secor as Chief Underwriting Officer of US E&S Insurer Hamilton Select

Business Wire

10 months ago

Hamilton Appoints Jamie Secor as Chief Underwriting Officer of US E&S Insurer Hamilton Select

Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock

Business Wire

10 months ago

Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Business Wire

10 months ago

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Q3 Traditional Fast Food Earnings: Arcos Dorados (NYSE:ARCO) Impresses

StockStory

10 months ago

Q3 Traditional Fast Food Earnings: Arcos Dorados (NYSE:ARCO) Impresses

Howard Hughes, Carrier, and More Stocks See Action From Activist Investors

Barrons.com

10 months ago

Howard Hughes, Carrier, and More Stocks See Action From Activist Investors

Newsfile

10 months ago

Equinox Gold Produces 564,500 Ounces of Gold in 2023, Reports 155,000 Ounces of Gold Produced in Fourth Quarter

Is It Too Late To Consider Buying CSG Systems International, Inc. (NASDAQ:CSGS)?

Simply Wall St.

10 months ago

Is It Too Late To Consider Buying CSG Systems International, Inc. (NASDAQ:CSGS)?

Tiger Woods Breaks Up With Nike. Will On Holding Be His New Home?

Motley Fool

10 months ago

Tiger Woods Breaks Up With Nike. Will On Holding Be His New Home?

Shareholders in National Vision Holdings (NASDAQ:EYE) are in the red if they invested three years ago

Simply Wall St.

10 months ago

Shareholders in National Vision Holdings (NASDAQ:EYE) are in the red if they invested three years ago

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?

Simply Wall St.

10 months ago

Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

Business Wire

10 months ago

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

Enovix and Group14 Announce Collaboration to Develop Best-in-Class Silicon Batteries

GlobeNewswire

10 months ago

Enovix and Group14 Announce Collaboration to Develop Best-in-Class Silicon Batteries

3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond

Motley Fool

10 months ago

3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond

Intellia to lay off staff, cut some early research

BioPharma Dive

10 months ago

Intellia to lay off staff, cut some early research

Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

10 months ago

Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Time to Buy These Top-Rated Security and Safety Services Stocks

Zacks

a year ago

Time to Buy These Top-Rated Security and Safety Services Stocks

15 Best Earthquake Insurance Companies Heading into 2024

Insider Monkey

a year ago

15 Best Earthquake Insurance Companies Heading into 2024

Salesforce upgraded, Chipotle downgraded: Wall Street's top analyst calls

The Fly

a year ago

Salesforce upgraded, Chipotle downgraded: Wall Street's top analyst calls

Is M/I Homes, Inc.'s (NYSE:MHO) Latest Stock Performance A Reflection Of Its Financial Health?

Simply Wall St.

a year ago

Is M/I Homes, Inc.'s (NYSE:MHO) Latest Stock Performance A Reflection Of Its Financial Health?

Do WaFd's (NASDAQ:WAFD) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do WaFd's (NASDAQ:WAFD) Earnings Warrant Your Attention?

Business Wire

a year ago

Viridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended Half-Life for Pivotal Development in Thyroid Eye Disease

These 8 Winning Bank Stocks Are 12% of My Portfolio. Here Is What I Think About All of Them.

Motley Fool

a year ago

These 8 Winning Bank Stocks Are 12% of My Portfolio. Here Is What I Think About All of Them.

13 Penny Stocks that Captured the Attention of Billionaires

Insider Monkey

a year ago

13 Penny Stocks that Captured the Attention of Billionaires

Victor Joseph Promoted to President & Chief Operating Officer of Mercury General Corporation

PR Newswire

a year ago

Victor Joseph Promoted to President & Chief Operating Officer of Mercury General Corporation

Wall Street Analysts Think Afya (AFYA) Is a Good Investment: Is It?

Zacks

a year ago

Wall Street Analysts Think Afya (AFYA) Is a Good Investment: Is It?

Should You Buy Tennant Company (NYSE:TNC) For Its Upcoming Dividend?

Simply Wall St.

a year ago

Should You Buy Tennant Company (NYSE:TNC) For Its Upcoming Dividend?

Viator Partners with Thoughtworks to Scale Power of Platforms to Enhance Traveler Experiences

Business Wire

a year ago

Viator Partners with Thoughtworks to Scale Power of Platforms to Enhance Traveler Experiences

Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference

Business Wire

a year ago

Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference

Equinox Gold's Greenstone Project: 96% Complete, Commissioning Underway

Newsfile

a year ago

Equinox Gold's Greenstone Project: 96% Complete, Commissioning Underway

Business Wire

a year ago

Grindr Brings Free At-Home HIV Self-Test Kits to Europe for the First Time With New Programs in Georgia and Ireland

Oil Price Tumbles Below $75 With Production at Record Levels

Zacks

a year ago

Oil Price Tumbles Below $75 With Production at Record Levels

Xenia Hotels & Resorts Declares Dividend For Fourth Quarter 2023 And Announces Board Approval For A $100 Million Increase In Share Repurchase Program

PR Newswire

a year ago

Xenia Hotels & Resorts Declares Dividend For Fourth Quarter 2023 And Announces Board Approval For A $100 Million Increase In Share Repurchase Program

Viridian Therapeutics Inc (VRDN) Reports Q3 2023 Financial Results and Corporate Progress

GuruFocus.com

a year ago

Viridian Therapeutics Inc (VRDN) Reports Q3 2023 Financial Results and Corporate Progress

GuruFocus.com

a year ago

Grindr Inc (GRND) Reports 39% Revenue Surge in Q3 2023, Ups Full-Year Outlook

Business Wire

a year ago

Grindr Inc. Reports Third Quarter 2023 Revenue Growth of 39%, Raises Guidance

Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Business Wire

a year ago

Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Business Wire

a year ago

Grindr Names Tolu Adeofe as Director of Investor Relations As It Approaches One Year Anniversary of its NYSE Listing

SFL - Third Quarter 2023 Results Presentation

GlobeNewswire

a year ago

SFL - Third Quarter 2023 Results Presentation

Brookfield Business Partners Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Brookfield Business Partners Reports Third Quarter 2023 Results

Share on Social Networks: